BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28935378)

  • 1. Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Real-world Case Series of Consecutive Patients Treated by a Single Multidisciplinary Team in the East of England From 1999 to 2015.
    Griffin JC; Sadullah S; Igali L; Shah NK; Wimperis JZ; Bowles KM
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e75-e78. PubMed ID: 28935378
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.
    Uherova P; Olson S; Thompson MA; Juskevicius R; Hamilton KS
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):105-10. PubMed ID: 15354734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
    Russell J; Collins A; Fowler A; Karanth M; Saha C; Docherty S; Padayatty J; Maw K; Lentell I; Cooke L; Hodson A; Shah N; Sadullah S; Grigoropoulos N; Qian W; Kirkwood AA; Uttenthal BJ; Johnson P; Follows GA
    Ann Hematol; 2021 Apr; 100(4):1049-1058. PubMed ID: 33641019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
    Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
    Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.
    Akhtar S; Rauf MS; Khafaga Y; Al-Kofide A; Elhassan TAM; Elshenawy MA; Nadri J; Mushtaq AH; Bakshi N; Shamayel M; Al-Sweedan S; Sarwar S; Maghfoor I
    BMC Cancer; 2021 Apr; 21(1):351. PubMed ID: 33794818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.
    Shivarov V; Ivanova M
    Br J Haematol; 2018 Sep; 182(5):727-730. PubMed ID: 28737250
    [No Abstract]   [Full Text] [Related]  

  • 7. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.
    Farrell K; McKay P; Leach M
    Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.
    Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH
    Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma and lymphocyte-rich classic Hodgkin lymphoma: role of immunohistochemistry].
    He YM; Li GD; Li FY; Jiang W; Ji H; Liao DY; Liu WP; Li YC; Li WF; Chen Y; Yang YH; Wang SX; Yang ZR
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):416-7. PubMed ID: 17822631
    [No Abstract]   [Full Text] [Related]  

  • 12. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
    Advani RH; Hoppe RT
    Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
    [No Abstract]   [Full Text] [Related]  

  • 13. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
    Borchmann S; Joffe E; Moskowitz CH; Zelenetz AD; Noy A; Portlock CS; Gerecitano JF; Batlevi CL; Caron PC; Drullinsky P; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz AJ; Owens CN; Palomba ML; Younes A; Straus DJ
    Blood; 2019 May; 133(20):2121-2129. PubMed ID: 30770396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of lymphoma in Bahrain. A retrospective analysis according to the World Health Organization classification.
    Aljufairi EA; George SM; Alshaikh SA; Radhi AA; Mohamed RM
    Saudi Med J; 2018 Jul; 39(7):736-739. PubMed ID: 29968899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
    Br J Haematol; 2012 May; 157(3):321-30. PubMed ID: 22360654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
    Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
    Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
    Xing KH; Connors JM; Lai A; Al-Mansour M; Sehn LH; Villa D; Klasa R; Shenkier T; Gascoyne RD; Skinnider B; Savage KJ
    Blood; 2014 Jun; 123(23):3567-73. PubMed ID: 24713929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience.
    Jackson C; Sirohi B; Cunningham D; Horwich A; Thomas K; Wotherspoon A
    Ann Oncol; 2010 Oct; 21(10):2061-2068. PubMed ID: 20332141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.